Close Button Icon
Doptelet (avatrombopag) Tablets Logo

You are about to leave DOPTELETHCP.com and go to an external page.

Please note that Sobi is not responsible for the content of the website you are about to visit.

CONTINUE

Go back

This information is intended for healthcare professionals in the United States.

Are you a healthcare professional?

Yes

No
Close Button Icon

Discover the Doptelet Copay Program

Eligible commercially insured patients may qualify for the Doptelet Connect program

What's the program?

  • Eligible patients may pay as little as $0 for each Doptelet prescription
  • Annual maximum benefit up to $15,000

Eligible patients must:

  • Have commercial insurance that covers Doptelet
  • Not be enrolled in any state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
  • Be 18 years of age or older
  • Be a resident in the United States or a US Territory

How to enroll:

  • Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
  • Patients can enroll themselves as well as their caregivers
  • Please call 1-833-368-2663 Monday–Friday 8 am–8 pm ET for more information

Terms and Conditions

  • Patients pay as little as $0 per prescription. Copay Program has an annual calendar cap of $15,000
  • The Copay Saving Program is void where prohibited by law, taxes, or restricted
  • This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
  • Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
  • The Patient Copay Program for Doptelet is not insurance and is not intended to substitute for insurance
  • Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Program
  • Certain information pertaining to your use of the Copay Program will be shared with Sobi, Inc., the sponsor of the Copay Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
  • Acceptance in this Program is not conditioned on any past, present, or future purchase, including additional doses
  • Enrollment for the Copay Program is valid through the calendar year
  • Sobi reserves the right to change program terms at any time
Close Button Icon
  • About Doptelet
  • Efficacy
  • Safety
  • Dosing
  • Access
  • Resources
  • Request a Rep
  • For US healthcare professionals only

  • Important Safety Information
  • Prescribing Information
  • Patient Information Leaflet
  • For Patients
Doptelet (avatrombopag) Tablets Logo

For US healthcare professionals only

  • About Doptelet
  • Efficacy
  • Safety
  • Dosing
  • Access
  • Resources
  • Request a Rep

Doptelet ConnectTM

Doptelet Connect is a free patient support program created by Sobi to provide individualized support to help eligible patients get access to Doptelet.

Doptelet Copay Program

The Doptelet Copay Program helps lower out-of-pocket costs for eligible patients receiving Doptelet. Eligible patients may pay as little as $0 per fill, up to a maximum $15,000 per calendar year.

See terms and conditions.

ENROLL NOW

Pay as Little as $0 Doptelet Copay Icon
Doptelet Download Icon

Doptelet Copay Program

Outlines how the Doptelet Copay Program can help lower out-of-pocket costs for eligible patients receiving Doptelet

Doptelet Download Icon

Patient Assistance Program Application

Assists patients who are underinsured or uninsured in determining their eligibility for financial assistance

View form en español

Dopetlet® (avatrombopag) Connect™ Logo

Doptelet Connect is a free patient support program created by Sobi to provide individualized support to help eligible patients get access to Doptelet. Doptelet Connect can assist your patients with insurance questions, financial support options, educational materials, and coordination around the specialty pharmacy process.

For more information, call 1-833-368-2663.
Doptelet Connect Case Managers are available Monday–Friday 8 AM–8 PM ET.

Any questions? We're here to help!

Doptelet Connect Case Managers can assist with:

Doptelet Connect Help Tools

Validating insurance coverage, navigating the insurance process, and providing tools to help eligible patients get access to Doptelet.

Doptelet Connect Help Question Bubbles

Answering logistical questions and providing education and coordination around the specialty pharmacy fulfillment process.

Doptelet Connect Financial Assistance Hand and Money

Providing financial assistance options for eligible patients.

How Doptelet Connect Works

Doptelet Download Icon

Prescription and Enrollment Form

Prescribes Doptelet and enrolls a patient into Doptelet Connect

View form en español

Doptelet Download Icon

Doptelet Connect Overview

Describes the Doptelet Connect support offerings available to your patients and your office

Doptelet Download Icon

Doptelet Connect Process Flow for Healthcare Professional (HCP) Offices

Explains relationship between the HCP offices and Doptelet Connect and the steps each may take during the access process

Doptelet Download Icon

Patient Consent Form

Authorization provides patient/caregiver access to the Doptelet Connect Patient Support Program

View form en español

Doptelet Access and Support Resource Guide

Offers a collection of digital resources for HCP office staff to navigate Doptelet access and reimbursement process.

DOWNLOAD

Inside the guide you will find…

Enrollment Guide

Doptelet Download Icon

Information to Help Complete the Prescription and Enrollment Form

Provides information on how to complete the Prescription and Enrollment Form

Doptelet Download Icon

Getting Started With Doptelet

Gives an overview of the Doptelet access process and the pathway options from prescription through continuing care

Accessing Doptelet Documents

Doptelet Download Icon

Doptelet Prior Authorization Resource Guide

Explains general steps in the PA process to help HCP offices get patients started on Doptelet

Doptelet Download Icon

Accessing Doptelet: Specialty Pharmacies and Distributors

Lists the contact information for the specialty pharmacies and distributors that are authorized to dispense Doptelet

Doptelet Download Icon

Coding Resource

Provides useful codes to identify appropriate patients and assists with the billing and reimbursement of Doptelet

Doptelet Download Icon

You’ve Been Prescribed Doptelet: Now What?

Outlines the process for patients in obtaining a Doptelet prescription with a Specialty Pharmacy

Have questions on access, support, and reimbursement?

Request to speak to a Field Reimbursement Manager (FRM) and they will reach out to you soon.

Request a Field Reimbursement Manager
Doptelet Platelet Character Football Players Talking
INDICATION & IMPORTANT
SAFETY INFORMATION

INDICATION

DOPTELET® (avatrombopag) is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Thrombotic/Thromboembolic Complications. DOPTELET is a thrombopoietin (TPO) receptor agonist and TPO receptor agonists have been associated with thrombotic complications in patients with chronic liver disease (0.4%; (1/274) in DOPTELET-treated patients) and thromboembolic complications in patients with chronic immune thrombocytopenia (7%; (9/128) in DOPTELET-treated patients). Portal vein thrombosis has been reported in patients with chronic liver disease, and thromboembolic events (arterial and venous) have been reported in patients with chronic immune thrombocytopenia treated with TPO receptor agonists.

Consider the potential increased thrombotic risk when administering DOPTELET to patients with known risk factors for thromboembolism, including genetic prothrombotic conditions.

DOPTELET should not be administered to patients with chronic liver disease or chronic immune thrombocytopenia in an attempt to normalize platelet counts. Monitor platelet counts and for signs and symptoms of thromboembolic events and institute treatment promptly.

Serious Adverse Reactions

The most common serious adverse reaction reported in DOPTELET-treated patients compared to placebo was hyponatremia (0.7% v. 0%).

Adverse Reactions

The most common adverse reactions (≥3%) in patients with chronic liver disease were: pyrexia, abdominal pain, nausea, headache, fatigue, and peripheral edema.

Postmarketing Experience

Following the approval of DOPTELET, hypersensitivity reactions involving the immune system, including, but not limited to, pruritus, rash, choking sensation, swollen face, and swollen tongue have been reported.

These are not all the possible risks associated with DOPTELET. Please see Full Prescribing Information for DOPTELET at www.doptelethcp.com

To report suspected adverse reactions, contact Sobi North America at 1-866-773-5274 or FDA at 1-800-FDA-1088.

For WAC pricing, visit doptelethcp.com/wac-pricing.

Sobi Rare Strength Logo
Terms of Use
Privacy Policy
Contact Us
Unsubscribe

Doptelet is a registered trademark of AkaRx, Inc.
Sobi is a trademark of Swedish Orphan Biovitrum AB (publ)
Doptelet Connect is a trademark of AkaRx, Inc.
© 2022 Sobi, Inc. – All rights reserved

PP-14800   04/22

INDICATION & IMPORTANT
SAFETY INFORMATION
Open ISI Button
Close ISI Button

INDICATION

DOPTELET® (avatrombopag) is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.

Scroll To Top Button

This website uses cookies. By continuing to use this website, you consent to our use of these cookies.

Read more about our use of cookies